190 related articles for article (PubMed ID: 37408643)
1.
Su BA; Chen CC; Chen HJ; Lai HY; Tsai CH; Lai CC; Tang HJ; Chao CM
Front Microbiol; 2023; 14():1186669. PubMed ID: 37408643
[TBL] [Abstract][Full Text] [Related]
2. Looking for
Ranieri EM; Denicolò S; Stolfa S; Dalfino L; Bavaro DF; Saracino A; Ronga L; Del Prete R; Mosca A
J Chemother; 2023 Nov; 35(7):610-613. PubMed ID: 37615040
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Phenotypic and Genotypic Diversity of
Bostanghadiri N; Ghalavand Z; Fallah F; Yadegar A; Ardebili A; Tarashi S; Pournajaf A; Mardaneh J; Shams S; Hashemi A
Front Microbiol; 2019; 10():1191. PubMed ID: 31191502
[No Abstract] [Full Text] [Related]
5.
Crémet L; Joffraud L; Eschapasse E; Bihouée T; Tissot A; Gibaud S; Persyn E
Microb Drug Resist; 2022 Aug; 28(8):877-881. PubMed ID: 35763306
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
Juhász E; Pongrácz J; Iván M; Kristóf K
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
[TBL] [Abstract][Full Text] [Related]
7. Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia.
Biagi M; Lamm D; Meyer K; Vialichka A; Jurkovic M; Patel S; Mendes RE; Bulman ZP; Wenzler E
Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32928733
[TBL] [Abstract][Full Text] [Related]
8. Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro.
Lin Q; Zou H; Chen X; Wu M; Ma D; Yu H; Niu S; Huang S
BMC Microbiol; 2021 Feb; 21(1):60. PubMed ID: 33618662
[TBL] [Abstract][Full Text] [Related]
9. In vitro combination of tigecycline with other antibiotics in Stenotrophomonas maltophilia isolates.
Karamanlıoğlu D; Dizbay M
Turk J Med Sci; 2019 Apr; 49(2):683-686. PubMed ID: 30866602
[TBL] [Abstract][Full Text] [Related]
10. Treatment approaches for severe Stenotrophomonas maltophilia infections.
Mojica MF; Bonomo RA; van Duin D
Curr Opin Infect Dis; 2023 Dec; 36(6):572-584. PubMed ID: 37846568
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients.
Araoka H; Baba M; Okada C; Abe M; Kimura M; Yoneyama A
Int J Infect Dis; 2017 May; 58():18-21. PubMed ID: 28257816
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
Usta E; Eroğlu C; Yanık K; Karadağ A; Güney AK; Günaydın M
Mikrobiyol Bul; 2015 Jan; 49(1):35-46. PubMed ID: 25706729
[TBL] [Abstract][Full Text] [Related]
13. Modulated Response of
Roisin L; Melloul E; Woerther PL; Royer G; Decousser JW; Guillot J; Dannaoui E; Botterel F
Front Cell Infect Microbiol; 2020; 10():574028. PubMed ID: 33123497
[No Abstract] [Full Text] [Related]
14. Antibiotic resistance, biofilm formation, and biofilm-associated genes among Stenotrophomonas maltophilia clinical isolates.
Bostanghadiri N; Ardebili A; Ghalavand Z; Teymouri S; Mirzarazi M; Goudarzi M; Ghasemi E; Hashemi A
BMC Res Notes; 2021 Apr; 14(1):151. PubMed ID: 33879237
[TBL] [Abstract][Full Text] [Related]
15. Biofilm eradication of Stenotrophomonas maltophilia by Levofloxacin and Trimethoprim-sulfamethoxazole.
Del Río-Chacón JM; Rojas-Larios F; Bocanegra-Ibarias P; Salas-Treviño D; Espinoza-Gómez F; Camacho-Ortiz A; Flores-Treviño S
Jpn J Infect Dis; 2024 Jan; ():. PubMed ID: 38296539
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of antibacterial activity of five biocides and the synergistic effect of biocide/EDTA combinations on biofilm-producing and non-producing Stenotrophomonas maltophilia strains isolated from clinical specimens in Iran.
Anari RK; Nikkhahi F; Javadi A; Bakht M; Rostamani M; Kelishomi FZ; Alizadeh SA
BMC Microbiol; 2022 Oct; 22(1):257. PubMed ID: 36271327
[TBL] [Abstract][Full Text] [Related]
17. The Relationship between the Biofilm Genes and Antibiotic Resistance in
Sameni F; Hajikhani B; Hashemi A; Owlia P; Niakan M; Dadashi M
Int J Microbiol; 2023; 2023():8873948. PubMed ID: 37692920
[TBL] [Abstract][Full Text] [Related]
18. Synergistic combination of aztreonam and ceftazidime/avibactam against resistant Stenotrophomonas maltophilia on pancreatitis.
De Almeida Torres N; Morales Junior R; Bueno Lopes LF; Zeigler R; Everson Uip D
J Infect Dev Ctries; 2023 Jun; 17(6):881-885. PubMed ID: 37406060
[TBL] [Abstract][Full Text] [Related]
19. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
[No Abstract] [Full Text] [Related]
20. Molecular Epidemiology of
Divakan H; Alikhani MY; Shokoohizadeh L
Oman Med J; 2023 May; 38(3):e505. PubMed ID: 37346891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]